This 286-page report provides a comprehensive analysis and profile of emerging cancer diagnostic tests and leading suppliers in the industry. It examines major categories of circulating and cellular diagnostic tests, including biochemical markers, oncogenes, growth factors, hormones, colony stimulating factors, lymphokines, and immunohistochemical stains. The report also provides profiles of major companies developing or marketing these diagnostic tests and evaluates the diagnostic prospects and medical rationale for emerging cancer diagnostic technologies.